All In Biotech

Drug Trial Radar · NCT05620940

A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.

A PHASE 1, OPEN-LABEL, EXPLORATORY, FIXED-SEQUENCE, PHARMACOKINETIC SINGLE ASCENDING DOSE STUDY OF IVL3004 VERSUS VIVITROL® (NALTREXONE) LONG-ACTING INJECTABLE (LAI) AND IVL4002 IN HEALTHY SUBJECTS

Last checked: Nov 20, 2026Latest source record: Sep 15, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Sep 11, 2024

Primary completion

Dec 30, 2025

Study completion Dec 30, 2025

Sponsor

Lead sponsor
Inventage Lab., Inc.Industry
Sponsor type
Industry
First posted
Nov 17, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Male only, from 18 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A Clinical Trial to Assess Pharmacokinetic Profiles, Safety and Tolerability of IVL3004 and IVL4002 in Healthy Male Subjects.

Conditions

  • Opioid Dependence
  • Alcohol Dependence
  • Multiple Sclerosis

Interventions

  • Vivitrol Injectable ProductDrug

    Naltrexone Long-Acting Injection

  • IVL3004Drug

    Naltrexone Long-Acting Injection

  • IVL4002Drug

    Naltrexone Long-Acting Injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. AUC0-240Time frame: Pre-dose, up to Day 57
  2. CmaxTime frame: Pre-dose, up to Day 57
  3. AUC240-672Time frame: Pre-dose, up to Day 57
  4. AUC0-672Time frame: Pre-dose, up to Day 57
  5. AUC0-infTime frame: Pre-dose, up to Day 57

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Nucleus Network

    Herston, Queensland, Australia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.